Inovio Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Net Income	-135.12	-279.82	-303.66	-166.41	-119.36	-96.97	-88.21	-73.74	-29.19	-36.12	Upgrade
Depreciation & Amortization	3.5	5.5	4.73	4.63	5.52	5	3.47	3.09	1.92	1.57	Upgrade
Share-Based Compensation	11.07	22.56	26.34	15.65	10.9	10.65	13.07	10.48	6.19	5.43	Upgrade
Other Operating Activities	-3.82	35.55	56.88	-31.84	5.09	7.77	8.46	-2.38	8.64	-0.7	Upgrade
Operating Cash Flow	-124.37	-216.22	-215.71	-177.98	-97.85	-73.55	-63.21	-62.56	-12.44	-29.82	Upgrade
Capital Expenditures	5.9	-0.97	-1.23	-1.52	-0.99	-2.09	-10.29	-3.94	-2.78	-1.38	Upgrade
Acquisitions	0	-2	0	35.95	0	0	0	0	0	0	Upgrade
Change in Investments	81.46	112.56	-174.11	-93.23	-8.06	44.5	-18.54	19.21	-53.04	-34.43	Upgrade
Other Investing Activities	-	-	-	-	-	-	1	1	1	-	Upgrade
Investing Cash Flow	87.36	109.59	-175.34	-58.8	-9.04	42.42	-27.83	16.27	-54.82	-35.81	Upgrade
Share Issuance / Repurchase	5.46	83.24	216.11	466.76	9.2	29.23	94.35	6.3	81.9	59.21	Upgrade
Debt Issued / Paid	0	0	0	0.17	94.13	0	0	0	0	0	Upgrade
Other Financing Activities	-0.47	-1.4	-4.61	-1.65	2.07	1.81	1.34	1.49	2.45	13.25	Upgrade
Financing Cash Flow	5	81.84	211.5	465.28	105.4	31.04	95.69	7.79	84.35	72.46	Upgrade
Exchange Rate Effect	-0	-0.03	-0.03	0.03	0	0	0	0	0	-0	Upgrade
Net Cash Flow	-32.02	-24.81	-179.58	228.53	-1.5	-0.09	4.65	-38.5	17.09	6.82	Upgrade
Free Cash Flow	-118.47	-217.18	-216.94	-179.5	-98.84	-75.64	-73.5	-66.49	-15.22	-31.2	Upgrade
Free Cash Flow Margin	-14238.67%	-2116.34%	-12223.61%	-2422.00%	-2403.69%	-248.13%	-174.09%	-188.00%	-37.51%	-298.41%	Upgrade
Free Cash Flow Per Share	-5.34	-10.92	-12.47	-13.88	-12.02	-9.81	-10.79	-10.90	-2.68	-6.33	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).